buclizine has been researched along with Heart Disease, Ischemic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boslett, J; Hemann, C; Lee, HC; Zhao, YJ; Zweier, JL | 1 |
1 other study(ies) available for buclizine and Heart Disease, Ischemic
| Article | Year |
|---|---|
Luteolinidin Protects the Postischemic Heart through CD38 Inhibition with Preservation of NAD(P)(H).
Topics: ADP-ribosyl Cyclase 1; Animals; Anthocyanins; Cardiotonic Agents; Dose-Response Relationship, Drug; Humans; Male; Membrane Glycoproteins; Myocardial Ischemia; NADP; Rats; Rats, Sprague-Dawley; Recombinant Proteins | 2017 |